NSE BSE
ipca laboratories ltd stock

IPCA LABORATORIES LTD Share Price

- - (%)
Sector: -

1633

524494

IPCALAB

img img img img
No Data Available

IPCA LABORATORIES LTD Share Price Update


As of the latest trading session, IPCA LABORATORIES LTD share price is currently at 1305, which is up by 3.30 from its previous closing. Today, the stock has fluctuated between 1299.55 and 1334.70. Over the past year, IPCA LABORATORIES LTD has achieved a return of 90.33 %. In the last month alone, the return has been -3.74 %.

IPCA LABORATORIES LTD Performance

Day Range

Low1299.55 High1334.70
1309.75

52 Week Range

Low 669.80 High 1374.60
1309.75

Open Price

1308.65

Prev. Close

1301.70

Volume (Shares)

31324.00

Total traded value

410.26

Upper Circuit

1366.75

Lower Circuit

1236.65

Note: The current prices & values are delayed, Login to your account for live updates.

IPCA LABORATORIES LTD Fundamentals


(Standalone)

Market Cap (Cr) 33228.90
PE Ratio (TTM) 60.41
Book Value / Share 244.58
Beta 0.70
ROE 8.91%
EPS (TTM) 21.70
Dividend Yield 0.31%
Net Profit Qtr (Cr) 136.94

IPCA LABORATORIES LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars DEC 2023 (Values in Cr)
Revenue 1506.83
Operating Expense 1323.57
Net Profit 136.94
Net Profit Margin (%) 9.08
Earnings Per Share (EPS) 5.40
EBITDA 290.38
Effective Tax Rate (%) 31.58
Particulars SEP 2023 (Values in Cr)
Revenue 1662.67
Operating Expense 1453.68
Net Profit 162.13
Net Profit Margin (%) 9.75
Earnings Per Share (EPS) 6.39
EBITDA 345.12
Effective Tax Rate (%) 33.85
Particulars JUN 2023 (Values in Cr)
Revenue 1486.34
Operating Expense 1279.92
Net Profit 166.58
Net Profit Margin (%) 11.20
Earnings Per Share (EPS) 6.57
EBITDA 340.69
Effective Tax Rate (%) 33.25
Particulars MAR 2023 (Values in Cr)
Revenue 1401.63
Operating Expense 1302.89
Net Profit 84.82
Net Profit Margin (%) 6.05
Earnings Per Share (EPS) 3.34
EBITDA 209.11
Effective Tax Rate (%) 35.84
Particulars DEC 2022 (Values in Cr)
Revenue 1440.11
Operating Expense 1297.81
Net Profit 115.18
Net Profit Margin (%) 7.99
Earnings Per Share (EPS) 4.54
EBITDA 235.31
Effective Tax Rate (%) 30.82
Particulars MAR 2023 (Values in Cr)
Revenue 5814.62
Operating Expense 5175.32
Net Profit 505.70
Net Profit Margin (%) 8.69
Earnings Per Share (EPS) 19.93
EBITDA 1023.04
Effective Tax Rate (%) 32.61
Particulars MAR 2022 (Values in Cr)
Revenue 5438.30
Operating Expense 4417.11
Net Profit 860.37
Net Profit Margin (%) 15.82
Earnings Per Share (EPS) 33.91
EBITDA 1291.00
Effective Tax Rate (%) 19.89
Particulars MAR 2021 (Values in Cr)
Revenue 5139.16
Operating Expense 3821.44
Net Profit 1140.77
Net Profit Margin (%) 22.19
Earnings Per Share (EPS) 90.08
EBITDA 1575.82
Effective Tax Rate (%) 17.33
Particulars MAR 2020 (Values in Cr)
Revenue 4367.43
Operating Expense 3647.15
Net Profit 652.46
Net Profit Margin (%) 14.93
Earnings Per Share (EPS) 51.64
EBITDA 979.45
Effective Tax Rate (%) 16.88
Particulars MAR 2019 (Values in Cr)
Revenue 3633.15
Operating Expense 3130.35
Net Profit 454.91
Net Profit Margin (%) 12.52
Earnings Per Share (EPS) 36.01
EBITDA 747.76
Effective Tax Rate (%) 18.38
Particulars MAR 2023 (Values in Cr)
Book Value / Share 230.27
ROE % 8.70
ROCE % 11.59
Total Debt to Total Equity 0.20
EBITDA Margin 16.90
Particulars MAR 2022 (Values in Cr)
Book Value / Share 215.41
ROE % 17.92
ROCE % 20.26
Total Debt to Total Equity 0.11
EBITDA Margin 23.66
Particulars MAR 2021 (Values in Cr)
Book Value / Share 370.65
ROE % 27.59
ROCE % 30.56
Total Debt to Total Equity 0.09
EBITDA Margin 29.71
Particulars MAR 2020 (Values in Cr)
Book Value / Share 286.15
ROE % 17.88
ROCE % 19.51
Total Debt to Total Equity 0.14
EBITDA Margin 20.85
Particulars MAR 2019 (Values in Cr)
Book Value / Share 247.12
ROE % 15.22
ROCE % 16.35
Total Debt to Total Equity 0.19
EBITDA Margin 19.91
Particulars MAR 2023 (Values in Cr)
Book Value / Share 231.66
ROE % 8.91
ROCE % 11.67
Total Debt to Total Equity 0.20
EBITDA Margin 17.64
Particulars MAR 2022 (Values in Cr)
Book Value / Share 215.84
ROE % 16.82
ROCE % 19.15
Total Debt to Total Equity 0.10
EBITDA Margin 23.80
Particulars MAR 2021 (Values in Cr)
Book Value / Share 374.67
ROE % 27.06
ROCE % 30.20
Total Debt to Total Equity 0.08
EBITDA Margin 30.72
Particulars MAR 2020 (Values in Cr)
Book Value / Share 290.11
ROE % 19.15
ROCE % 20.63
Total Debt to Total Equity 0.13
EBITDA Margin 22.50
Particulars MAR 2019 (Values in Cr)
Book Value / Share 248.25
ROE % 15.60
ROCE % 16.63
Total Debt to Total Equity 0.18
EBITDA Margin 20.65
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1706.06
Total Assets 8446.97
Total Liabilities 8446.97
Total Equity 5877.30
Share Outstanding 253704218
Price to Book Ratio 3.50
Return on Assets (%) 5.98
Return on Capital (%) 6.93
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 595.50
Total Assets 7438.44
Total Liabilities 7438.44
Total Equity 5475.76
Share Outstanding 253704218
Price to Book Ratio 4.92
Return on Assets (%) 11.56
Return on Capital (%) 13.8
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 306.92
Total Assets 6010.13
Total Liabilities 6010.13
Total Equity 4752.72
Share Outstanding 126852109
Price to Book Ratio 5.08
Return on Assets (%) 18.98
Return on Capital (%) 22.93
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 152.40
Total Assets 5184.57
Total Liabilities 5184.57
Total Equity 3677.54
Share Outstanding 126352109
Price to Book Ratio 4.78
Return on Assets (%) 12.58
Return on Capital (%) 16.05
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 259.81
Total Assets 4457.54
Total Liabilities 4457.54
Total Equity 3136.66
Share Outstanding 126352109
Price to Book Ratio 3.96
Return on Assets (%) 10.20
Return on Capital (%) 13.12
Particulars MAR 2023 (Values in Cr)
Net Income 745.29
Cash from Operations 1029.46
Cash from Investing -725.00
Cash from Financing 507.24
Net change in Cash 588.05
Free Cash Flow 1523.93
Particulars MAR 2022 (Values in Cr)
Net Income 1135.72
Cash from Operations 1058.11
Cash from Investing -855.05
Cash from Financing 426.78
Net change in Cash 427.80
Free Cash Flow 1537.06
Particulars MAR 2021 (Values in Cr)
Net Income 1388.98
Cash from Operations 1335.72
Cash from Investing -520.69
Cash from Financing -305.82
Net change in Cash 263.62
Free Cash Flow 1697.27
Particulars MAR 2020 (Values in Cr)
Net Income 738.89
Cash from Operations 722.57
Cash from Investing -509.65
Cash from Financing -136.54
Net change in Cash -75.84
Free Cash Flow 1028.85
Particulars MAR 2019 (Values in Cr)
Net Income 546.46
Cash from Operations 611.85
Cash from Investing -165.06
Cash from Financing -183.20
Net change in Cash 152.77
Free Cash Flow 792.39
Particulars MAR 2023 (Values in Cr)
Net Income 750.49
Cash from Operations 977.54
Cash from Investing -709.61
Cash from Financing 506.38
Net change in Cash 559.06
Free Cash Flow 1414.40
Particulars MAR 2022 (Values in Cr)
Net Income 1074.11
Cash from Operations 1023.88
Cash from Investing -814.00
Cash from Financing 426.04
Net change in Cash 443.76
Free Cash Flow 1475.51
Particulars MAR 2021 (Values in Cr)
Net Income 1379.96
Cash from Operations 1337.93
Cash from Investing -559.56
Cash from Financing -307.38
Net change in Cash 229.12
Free Cash Flow 1687.58
Particulars MAR 2020 (Values in Cr)
Net Income 784.97
Cash from Operations 707.84
Cash from Investing -499.13
Cash from Financing -138.67
Net change in Cash -76.37
Free Cash Flow 980.91
Particulars MAR 2019 (Values in Cr)
Net Income 557.39
Cash from Operations 603.31
Cash from Investing -122.98
Cash from Financing -222.83
Net change in Cash 149.84
Free Cash Flow 670.71
Company Name Price P/E P/B Market Cap 52 Week Low/High
IPCA LABORATORIES LTD 1310.90 64.96 5.40 33258.09 670.00 / 1373.95
BLISS GVS PHARMA LTD 110.40 12.07 1.19 1155.79 71.00 / 148.95
CIPLA LTD 1403.90 26.62 4.24 113350.18 913.20 / 1519.00
FERMENTA BIOTECH LIMITED 162.85 0.00 1.67 479.28 132.30 / 214.00
GLAXOSMITHKLINE PHARMA LT 2355.75 57.70 22.44 39907.83 1275.05 / 2649.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
IPCA LABORATORIES LTD 1310.90 60.41 5.35 33258.09 670.00 / 1373.95
AMRUTAJAN HEALTH LTD 743.15 48.83 8.20 2148.49 556.05 / 802.60
ASTRAZENECA PHARMA IND LT 5757.35 90.24 21.97 14393.38 3131.10 / 7208.00
BLISS GVS PHARMA LTD 110.40 15.25 1.16 1155.79 71.00 / 148.95
ABBOTT INDIA LIMITED 26643.70 47.13 15.30 56617.86 20594.25 / 29628.15

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 1294.90
  • 26 Days 1310.30
  • 10 Days 1301.10
  • 50 Days 1277.70
  • 12 Days 1304.30
  • 100 Days 1221.20
  • 20 Days 1314.10
  • 200 Days 849.80
1283.73
PIVOT
First Resistance 1297.67
Second Resistance 1307.83
Third Resistance 1321.77
First Support 1273.57
Second Support 1259.63
Third Support 1249.47
RSI 41.83
MACD -5.93
Commodity Channel Index (CCI) -75.11
ADX 26.47
Williams % R -54.25

Over 1 Month

down

-3.74

Over 3 Months

down

5.31

Over 6 Months

down

20.41

Over 1 Year

down

90.33

Over 3 Years

down

6.09

Over 5 Years

down

23.14

IPCA LABORATORIES LTD Future

Future: Price

30 May
1285.20
27 Jun
1279.60
25 May
0 100 200 300 400 500 600

Discount/Premium

30 May
8.90
27 Jun
3.30
25 May
0 1 2 3 4 5 6 7

Active Calls

1400.0
90
1300.0
69
1360.0
60
25 May
0 500 1000 1500 2000 2500 3000

Active Puts

1260.0
96
1200.0
72
1240.0
61
25 Jul
0 500 1000 1500 2000 2500

IPCA LABORATORIES LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
0.0
Promoter Holdings
0.0
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%

IPCA LABORATORIES LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-11-22 2.0 Interim 2023-11-22 Equity shares 2022-11-22 4.0 Interim 2022-11-23 Equity shares 2021-11-22 8.0 Interim 2021-11-23 Equity shares 2020-11-13 8.0 Interim 2020-11-17 Equity shares 2020-02-18 5.0 Interim 2020-02-20 Equity shares 2019-08-06 3.0 Final 2019-08-08 Equity shares 2018-08-02 1.0 Final 2018-08-04 Equity shares 2017-07-27 1.0 Final 2017-07-29 Equity shares 2015-07-22 1.0 Final 2015-07-24 Equity shares 2014-07-18 2.5 Final 2014-07-22 Equity shares 2013-10-31 2.5 Interim 2013-11-01 Equity shares 2013-07-19 2.0 Final 2013-07-23 Equity shares 2012-11-01 2.0 Interim 2012-11-02 Equity shares 2012-07-20 1.2 Final 2012-07-24 Equity shares 2012-02-07 1.0 Interim 2 2012-02-08 Equity shares 2011-11-03 1.0 Interim 2011-11-07 Equity shares 2011-07-18 1.2 Final 2011-07-20 Equity shares 2011-02-01 1.0 Interim 2 2011-02-02 Equity shares 2010-10-28 1.0 Interim 2010-10-29 Equity shares 2010-07-16 1.0 Final 2010-07-20 Equity shares 2010-01-27 4.0 Interim 2 2010-01-28 Equity shares 2009-10-30 5.0 Interim 2009-11-03 Equity shares 2009-07-20 4.0 Final 2009-07-22 Equity shares 2009-01-27 3.0 Interim 2 2009-01-28 Equity shares 2008-11-07 4.0 Interim 2008-11-10 Equity shares 2008-07-14 4.5 Final 2008-07-16 Equity shares 2007-11-06 3.5 Interim 2007-11-07 Equity shares 2007-07-10 4.0 Final 2007-07-12 Equity shares 2006-11-02 3.5 Interim 0001-01-01 Equity shares 2005-11-09 0.0 Interim 2005-11-10 Equity shares 2005-09-13 0.0 Final 2005-09-15 Equity shares
Ex-Date Ex-Bonus Ratio
2005-01-31 2005-01-28 1:1
Ex-Date Old FV NEW FV Record Date
2022-01-10 2.0 1.0 2022-01-11 2010-03-22 10.0 2.0 2010-03-23

Learn More About Stocks

About IPCA LABORATORIES LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by IPCA LABORATORIES LTD

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Ipca Laboratories Ltd?

Answer Field

The share price of Ipca Laboratories Ltd for NSE is ₹ 1305 and for BSE is ₹ 1310.9.

What is the Market Cap of Ipca Laboratories Ltd?

Answer Field

The market cap of Ipca Laboratories Ltd for NSE is ₹ 33,228.90 Cr. and for BSE is ₹ 0.0 Cr. as of now.

What is the 52 Week High and Low of Ipca Laboratories Ltd?

Answer Field

The 52 Week High and Low of Ipca Laboratories Ltd for NSE is ₹ 1374.60 and ₹ 669.80 and for BSE is ₹ 1373.95 and ₹ 670.00.

How to Buy Ipca Laboratories Ltd share?

Answer Field

You can trade in Ipca Laboratories Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Ipca Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been 90.33%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7 Lac+ Users

icon-with-text

4.3 App Rating

icon-with-text

4 Languages

icon-with-text

₹ 3800 Cr MTF Book

icon-with-text
loader